| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.077 | 0.6 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |